Global investments into neglected disease R&D
The G-FINDER project tracks and reports on global investments into research and development (R&D) for neglected diseases.
G-FINDER is a uniquely informative data source, providing policy-makers, donors, researchers and industry with an understanding of the landscape for neglected disease R&D, where funding gaps exist, and how their investments fit into the global picture:
- in 33 neglected diseases;
- across 142 product areas for these diseases including drugs, vaccines, diagnostics, microbicides and vector control products; and
- in platform technologies (e.g. adjuvants, delivery technologies, diagnostic platforms)
The data includes all types of product-related R&D, including basic research, discovery and pre-clinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.
Funded by the Bill & Melinda Gates Foundation since inception, the G-FINDER project was originally hosted at The George Institute for International Health and then run by Policy Cures from 2010. Following the establishment of Policy Cures Research (PCR) as a separate organisations in 2016, the G-FINDER project is conducted by Policy Cures Research.